- Home
- PTGX vs CHE Comparison
PTGX vs CHE Comparison
Compare PTGX & CHE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PTGX | CHE |
|---|---|---|
| Founded | 2006 | 1970 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Nursing Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.4B | 6.2B |
| IPO Year | 2016 | N/A |
Fundamental Metrics
Financial Performance| Metric | PTGX | CHE |
|---|---|---|
| Price | $82.46 | $439.72 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 4 |
| Target Price | $93.00 | ★ $574.25 |
| AVG Volume (30 Days) | ★ 909.6K | 140.4K |
| Earning Date | 02-20-2026 | 02-25-2026 |
| Dividend Yield | N/A | ★ 0.54% |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.72 | ★ 18.95 |
| Revenue | $209,217,000.00 | ★ $2,530,634,000.00 |
| Revenue This Year | N/A | $5.91 |
| Revenue Next Year | $288.98 | $6.21 |
| P/E Ratio | $114.23 | ★ $23.28 |
| Revenue Growth | N/A | ★ 6.45 |
| 52 Week Low | $33.70 | $408.42 |
| 52 Week High | $96.54 | $623.61 |
Technical Indicators
Market Signals| Indicator | PTGX | CHE |
|---|---|---|
| Relative Strength Index (RSI) | 35.78 | 56.42 |
| Support Level | $84.11 | $421.34 |
| Resistance Level | $89.61 | $443.79 |
| Average True Range (ATR) | 3.13 | 8.84 |
| MACD | -1.11 | 1.22 |
| Stochastic Oscillator | 19.24 | 81.12 |
Price Performance
Historical ComparisonAbout PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.
About CHE Chemed Corp
Chemed Corp purchases, operates, and divests subsidiaries engaged in diverse business activities to maximize shareholder value. Through its subsidiaries, the company operates in the following segments: VITAS and Roto-Rooter. The VITAS segment generates the majority of the firm's revenue and provides hospice and palliative care services to patients with terminal illnesses through a network of physicians, registered nurses, home health aides, social workers, and volunteers. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and related services to residential and commercial customers.